Bronte Capital Management Pty Ltd.
Long book
$940.9M
Q1 2026
Positions
51
Top-10 weight
74%
concentration
Last quarter
+10.6%
SPY +14.8%
Turnover
19%
of book per quarter
Strategy in plain words
auto-generated from filingsBronte Capital Management Pty Ltd. is a concentrated fundamental stock-picker, running a $940.9M US long book across 51 positions.
The portfolio is concentrated: the top 10 names carry 74% of the portfolio. Turnover is modest: positions are typically held for years. Current anchor positions: REGENERON PHARMACEUTICALS, ALPHABET INC-CL A, INTERACTIVE BROKERS GRO-CL A, BERKSHIRE HATHAWAY INC-CL B, VISA INC-CLASS A SHARES.
Over the last 9 quarters its long book ran on average 0pp per quarter ahead of the S&P 500, beating the index in 5 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+5.8%
Q2 2024
+3.2%
Q3 2024
+0.4%
Q4 2024
-2.7%
Q1 2025
+6.3%
Q2 2025
+8.6%
Q3 2025
+11.4%
Q4 2025
-3.2%
Q1 2026
+10.6%
Sector allocation
Financials 29%
Healthcare 22%
Technology 18%
Consumer staples 14%
Consumer discretionary 12%
Services media 4%
Materials 2%
Long book by quarter
What does Bronte Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS | Healthcare | 172.8K | $133.5M | 14.2% | -2.3% |
| GOOGL ALPHABET INC-CL A | Technology | 381.5K | $109.7M | 11.7% | -8.3% |
| IBKR INTERACTIVE BROKERS GRO-CL A | Financials | 1.3M | $86.0M | 9.1% | -13.8% |
| BRK/B BERKSHIRE HATHAWAY INC-CL B | Financials | 155.1K | $74.3M | 7.9% | -4.5% |
| AMZN AMAZON.COM INC | Consumer discretionary | 285.7K | $59.5M | 6.3% | +2.9% |
| PM PHILIP MORRIS INTERNATIONAL | Consumer staples | 341.1K | $56.4M | 6.0% | -14.4% |
| CTVA CORTEVA INC | Consumer staples | 502.8K | $42.1M | 4.5% | -11.6% |
| COF CAPITAL ONE FINANCIAL CORP | Financials | 187.4K | $34.2M | 3.6% | +6.7% |
| FCNCA FIRST CITIZENS BCSHS -CL A | Financials | 16.5K | $31.1M | 3.3% | -3.4% |
| DIS WALT DISNEY CO/THE | Services media | 185.7K | $17.9M | 1.9% | New |
| TBBB BBB FOODS INC-CLASS A | Consumer discretionary | 487.6K | $17.2M | 1.8% | +23.7% |
| NKTR NEKTAR THERAPEUTICS | Healthcare | 198.3K | $14.3M | 1.5% | New |
| HLF HERBALIFE LTD | Consumer discretionary | 939.9K | $13.8M | 1.5% | -16.1% |
| GHC GRAHAM HOLDINGS CO-CLASS B | Services media | 12.8K | $13.5M | 1.4% | -4.3% |
| ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 37.2K | $12.3M | 1.3% | -4.2% |
| SHC SOTERA HEALTH CO | Healthcare | 843.7K | $12.1M | 1.3% | -3.6% |
| AUR AURORA INNOVATION INC | Technology | 2.3M | $9.6M | 1.0% | New |
| NEM NEWMONT CORP | Materials | 75.4K | $8.2M | 0.9% | -3.1% |
| PINS PINTEREST INC- CLASS A | Technology | 430.9K | $7.9M | 0.8% | -15.9% |
| GLBE GLOBAL-E ONLINE LTD | Technology | 213.1K | $6.6M | 0.7% | New |
| B BARRICK MINING CORP | Materials | 158.7K | $6.5M | 0.7% | -3.7% |
| RAMP LIVERAMP HOLDINGS INC | Technology | 223.2K | $5.9M | 0.6% | -3.8% |
| PCTY PAYLOCITY HOLDING CORP | Technology | 36.6K | $4.0M | 0.4% | New |
| TPB TURNING POINT BRANDS INC | Consumer staples | 42.9K | $3.7M | 0.4% | +75.9% |
| MDLZ MONDELEZ INTERNATIONAL INC-A | Consumer staples | 56.0K | $3.2M | 0.3% | -13.3% |
| SBH SALLY BEAUTY HOLDINGS INC | Consumer discretionary | 220.7K | $3.1M | 0.3% | -70.1% |
| BBWI BATH & BODY WORKS INC | Consumer discretionary | 155.5K | $2.9M | 0.3% | -38.9% |
| BF/A BROWN-FORMAN CORP-CLASS A | Consumer staples | 100.4K | $2.7M | 0.3% | New |
| JRVR JAMES RIVER GROUP HOLDINGS I | Financials | 339.0K | $2.1M | 0.2% | +174.3% |
| RSKD RISKIFIED LTD-A | Services media | 488.5K | $1.9M | 0.2% | -4.9% |
| OLED UNIVERSAL DISPLAY CORP | Technology | 11.1K | $1.0M | 0.1% | -4.6% |
| VRSK VERISK ANALYTICS INC | Technology | 2.9K | $551K | 0.1% | New |
| ENVX ENOVIX CORP | Technology | 11.6K | $60K | 0.0% | Held |
| ALEC ALECTOR INC | Healthcare | 19.3K | $41K | 0.0% | Held |
| CHRS COHERUS ONCOLOGY INC | Healthcare | 19.3K | $33K | 0.0% | Held |
| CRBU CARIBOU BIOSCIENCES INC | Healthcare | 15.6K | $30K | 0.0% | Held |
| FATE FATE THERAPEUTICS INC | Healthcare | 22.9K | $27K | 0.0% | Held |
| CCCC C4 THERAPEUTICS INC | Healthcare | 10.0K | $26K | 0.0% | Held |
| PLRX PLIANT THERAPEUTICS INC | Healthcare | 18.6K | $23K | 0.0% | Held |
| IVVD INVIVYD INC | Healthcare | 11.0K | $14K | 0.0% | Held |
| MIST MILESTONE PHARMACEUTICALS IN | Healthcare | 10.4K | $12K | 0.0% | Held |
| RANI RANI THERAPEUTICS HOLDINGS-A | Healthcare | 14.9K | $11K | 0.0% | Held |
| GUTS FRACTYL HEALTH INC | Healthcare | 16.9K | $8K | 0.0% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | Apr 27, 2026 | 54 | $1.01B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 3, 2026 | 44 | $1.00B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 5, 2025 | 30 | $1.12B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 12, 2025 | 27 | $1.27B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 14, 2025 | 26 | $1.23B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 10, 2025 | 24 | $1.27B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 5, 2024 | 25 | $1.23B | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 7, 2024 | 28 | $1.28B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 13, 2024 | 30 | $1.23B | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP